Please bring another victory to Sen.
Bernie Sanders (I-Vt.).
The Senate Support Committee was scheduled to vote on a subpoena for Johnson & Johnson CEO testimony on January 31st. Joaquin Duato and Merck CEO robert davisHowever, Sanders said that is no longer necessary.
The two will become CEOs of Bristol-Myers Squibb. chris bernerSanders announced at a hearing in February that he had previously agreed to testify.
These were to be the first subpoenas issued by the HELP Committee in 2016. is more than 40 years.
“The use of subpoenas is clearly a last resort, and I am pleased that these CEOs have volunteered to serve on the committee,” Sanders said in a statement.
The situation is reminiscent of last year, when Sanders threatened to subpoena the testimony of then-Starbucks CEO Howard Schultz. Schultz finally agreed to testify the day before the subpoena vote.
The Vermont senator said he wants executives to explain why their companies are charging. significantly higher price Healthcare in the United States compared to other countries.
All three companies manufacture parts of it.
most expensive medicine In the United States, it is also sold as a diabetes treatment drug. Janubia Merck's blood cancer treatment Imbruvica It is sold as a blood thinner by Johnson & Johnson. Eliquis From Bristol-Myers Squibb.
Merck previously said Sanders' planned subpoena would be act of retaliation The committee's decision to sue the federal government over the Medicare drug price negotiation program that Democrats signed into law in 2022.
Johnson & Johnson said in a statement Friday that the company looks forward to “deepening our understanding of our long-standing efforts to improve affordability and access to medicines.”
